AnovaOS Network Powered Patient Registry
The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.
Conditions:
Infectious Disease Neoplasms Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) Endocrine, Nutritional and Metabolic Diseases (E00-E89) Mental and Behavioural Disorders Diseases of the Nervous System Diseases of the Eye and Adnexa Diseases of the Ear and Mastoid Process Diseases of the Circulatory System Diseases of the Respiratory System Diseases of the Digestive System Diseases of the Skin and Subcutaneous Tissue Diseases of the Musculoskeletal System and Connective Tissue Diseases of the Genitourinary System Pregnancy, Childbirth and the Puerperium Certain Conditions Originating in the Perinatal Period Congenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99) Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified Injury, Poisoning and Certain Other Consequences of External Causes External Causes of Morbidity and Mortality Factors Influencing Health Status and Contact With Health Services
Study Start (Actual) 2021-09-01
Primary Completion (Estimated) 2025-08-31
Study Completion (Estimated) 2026-08-31
Enrollment (Estimated) 100000
Study Type OBSERVATIONAL
Phase N/A
Locations:
📍 Arlington Heights, Illinois, United States

Eligibility Criteria

Description

    Inclusion Criteria:

    • * 18 years old or older;
    • * Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;
    • * Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;
    • * Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;
    • * Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy;
    • * Anticipated additional follow up with the registry once per year.

    Exclusion Criteria:

    • * Subjects who do not meet the inclusion criteria for the study;
    • * Subjects who are unable to understand the protocol or unable to provide legally effective informed consent
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted2021-08-18
  • First Submitted that Met QC Criteria2021-08-18
  • First Posted2021-08-20

Study Record Updates

  • Last Update Submitted that Met QC Criteria2024-01-29
  • Last Update Posted2024-01-30
  • Last Verified2024-01